High - dose influenza vaccine is 24 percent more effective than the standard - dose vaccine in protecting persons ages 65 and
over against influenza illness and its complications, according to a Vanderbilt - led study published today in the New England Journal of Medicine (NEJM).
Not exact matches
Researchers concluded that the high - dose vaccine is safe, induces significantly higher antibody responses, and provides superior protection
against laboratory - confirmed
influenza illness compared to standard dose among persons
over 65 years of age.